Your browser doesn't support javascript.
loading
Insights on Multiple Myeloma Treatment Strategies.
Mateos, María-Victoria; Ludwig, Heinz; Bazarbachi, Ali; Beksac, Meral; Bladé, Joan; Boccadoro, Mario; Cavo, Michele; Delforge, Michel; Dimopoulos, Meletios A; Facon, Thierry; Geraldes, Catarina; Goldschmidt, Hartmut; Hájek, Roman; Hansson, Markus; Jamroziak, Krzysztof; Leiba, Merav; Masszi, Tamás; Mendeleeva, Larisa; O'Dwyer, Michael; Plesner, Torben; San-Miguel, Jesús F; Straka, Christian; van de Donk, Niels W C J; Yong, Kwee; Zver, Samo; Moreau, Philippe; Sonneveld, Pieter.
Afiliação
  • Mateos MV; Complejo Asistencial Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (CAUSA/IBSAL), Salamanca, Spain.
  • Ludwig H; Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria.
  • Bazarbachi A; Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
  • Beksac M; Ankara University School of Medicine, Ankara, Turkey.
  • Bladé J; Institut d'Investigac'ons Biomedques August Pi Sunyer (IDiBAPS), Barcelona, Spain.
  • Boccadoro M; University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
  • Cavo M; Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy.
  • Delforge M; University Hospital Leuven, Leuven, Belgium.
  • Dimopoulos MA; School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Facon T; Service des Maladies du Sang, Hôpital Claude Huriez, Lille, France.
  • Geraldes C; Hospital and University Centre of Coimbra, Coimbra, Portugal.
  • Goldschmidt H; Department of Internal Medicine V, University Clinic Heidelberg and National Center of Tumor Diseases, Heidelberg, Germany.
  • Hájek R; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Hansson M; Department of Hematology, Skåne University Hospital und Lund University, Lund, Sweden.
  • Jamroziak K; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Leiba M; Assuta Ashdod University Hospital, Faculty of Health Science, Ben-Gurion University of the Negev, Negev, Israel.
  • Masszi T; 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Mendeleeva L; National Research Center for Hematology of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
  • O'Dwyer M; Galway University Hospital, Galway, Ireland.
  • Plesner T; Vejle Hospital and University of Southern Denmark, Vejle, Denmark.
  • San-Miguel JF; Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain.
  • Straka C; Klinikum Schwabing, München, Germany.
  • van de Donk NWCJ; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
  • Yong K; Cancer Institute, University College London, London, United Kingdom.
  • Zver S; University Clinical Center Ljubljana and Medical Faculty, Ljubljana, Slovenia.
  • Moreau P; University of Nantes, Nantes, France.
  • Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Hemasphere ; 3(1): e163, 2019 Feb.
Article em En | MEDLINE | ID: mdl-31723802
ABSTRACT
The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical practice, healthcare professionals are now faced with challenges including, optimal treatment sequencing and changing treatment goals. In light of this, a group of experts met to discuss diagnostic and treatment guidelines, examine current clinical practice, and consider how new clinical trial data may be integrated into the management of multiple myeloma in the future.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2019 Tipo de documento: Article